



COMPARATIVE STUDY OF THE ANTINOCICEPTIVE ACTION OF AMITRIPTYLINE WITH 




PHULEN SARMA1*, DAISY PHUKAN2 
1MD Pharmacology Resident, 2
Received: 03 Jun 2018 Revised and Accepted: 26 Sep 2018 
Associate Professor, Department of Pharmacology, Assam Medical College and Hospital 
Email: phulen10@gmail.com 
ABSTRACT 
Objective: The aim of our study was to compare the anti-nociceptive action of amitriptyline with fluoxetine and evaluation of their probable 
mechanism of anti-nociceptive action by observing their individual interactions with morphine, naloxone, yohimbine, and ondansetron. 
Methods: Albino mice weighing 25-35 grams were taken and divided into 12 groups. Group A-Control(distilled water), Group B-amitriptyline 20 
mg/kg, Group C-fluoxetine 20 mg/kg, Group D-morphine 5 mg/kg, Group E-amitriptyline 20 mg/kg+ morphine 5 mg/kg, Group F-amitriptyline 20 
mg/kg+ naloxone 3 mg/kg, Group G-amitriptyline 20 mg/kg+ yohimbine 2 mg/kg, Group H-amitriptyline 20 mg/kg+ ondansetron 0.1 mg/kg, Group I-
fluoxetine 20 mg/kg+morphine 5 mg/kg, Group J-fluoxetine 20 mg/kg+ naloxone 3 mg/kg, Group K-fluoxetine 20 mg/kg+ yohimbine 2 mg/kg and 
Group L-fluoxetine 20 mg/kg+ ondansetron 0.1 mg/kg. Hot plate method and acetic acid writhing test were used to assess central and peripheral 
analgesic activity respectively. 
Results: Both the amitriptyline and fluoxetine-treated animals showed significantly increased reaction time in a hot plate (p<0.05) and a significant 
decrease in the number of wriths in acetic acid writhing test (p<0.05), when compared with control. Animals in amitriptyline group showed 
significantly higher reaction time and less number of wriths when compared to fluoxetine group. Morphine increased, while naloxone, yohimbine and 
ondansetron decreased the reaction time in a hot plate. In the acetic acid writhing test, a number of wriths significantly decreased when co-treated 
with morphine and increased when co-treated with naloxone, yohimbine and ondansetron. 
Conclusion: It is concluded that amitriptyline is a better antinociceptive agent than fluoxetine. Their central and peripheral mechanism of 
antinociception both involve opioidergic, serotonergic and noradrenergic pathway. 
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Pain is an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage or described in terms of such 
damage [1]. In the pain pathway, Aδ and C fibres carrying pain 
terminate in the dorsal horn and excite second order neurons to reach 
thalamus. From these thalamic areas, the signals are transmitted to 
basal areas of the brain, as well as to the somatosensory cortex [2]. 
Endogenous ascending pain modulation occurs at the level of dorsal 
horn by gate control mechanism. Major components of descending 
pain control are periaqueductal gray (PAG) and periventricular areas, 
raphe magnus nucleus (NRM) and pain inhibitory complex located in 
the dorsal horns of the spinal cord [2]. 
Several transmitter substances are involved in the analgesia system; 
especially involved are endogenous opioid peptides (encephalin), 
serotonin [2] and norepinephrine [3, 4]. The role of opioidergic 
pathway is well known. Encephalin causes both presynaptic and 
postsynaptic inhibition of incoming type C and types Aδ pain fibers 
at their synapse in dorsal horn [2]. Regarding the role of serotonin, 
analgesia produced by spinal injection of serotonin (5-HT) appears 
to be mediated primarily through 5-HT3 receptors [5]. Pretreatment 
with tropisetran (5HT3 antagonist) reversed the antinociceptive 
action of intrathecally administered 5-HT [6]. 5HT3 receptors are 
implicated in the antinociceptive action of paroxetine 
(antidepressant of selective serotonin reuptake inhibitor class) as 
ondansetron (5-HT3 antagonist) inhibited its antinociceptive activity 
[7]. Regarding the role of the noradrenergic pathway in pain 
modulation, the noradrenergic pathway from the locus coeruleus 
also has an inhibitory effect on transmission in the dorsal horn [3]. It 
was found that α-2 play an important role in antidepressant-induced 
antinociception as RX821002 (α-2 antagonist) could block their 
antinociceptive action but prazosin (α-1 adrenoceptor antagonist) 
could not [8]. In the spinal cord, norepinephrine released from 
descending pathways suppresses pain primarily by acting through 
α-2 receptors [4]. 
Amitriptyline is a tricyclic antidepressant. fluoxetine is an 
antidepressant of the selective serotonin reuptake inhibitor (SSRI) 
class [9]. In the treatment of neuropathic and other pain disorders, 
antidepressants are being used, but among these which agents are 
preferable, there is a universal doubt. Studies reveal contradictory 
and insufficient results. Rani et al., 1996[10] in their study on 
amitriptyline versus fluoxetine in pain conditions found that 
fluoxetine was superior. Nisha Michael et al., 2012 [11] in their 
comparative study between amitriptyline and fluoxetine found 
amitriptyline to be superior. The mechanism of antinociceptive 
action of these antidepressant Compounds (amitriptyline and 
fluoxetine) are not yet known. But the onset of analgesic effect of 
Tricyclic antidepressants is earlier and it occurs at a lower dose than 
that is typically required for management of depression [12]. So, in 
our study, we have done a comparative analysis of the 
antinociceptive activity of amitriptyline and fluoxetine and evaluated 
the probable mechanism of this action. 
MATERIALS AND METHODS 
Drugs and chemicals 
Amitriptyline was obtained from Himedia Labs, Bangalore. fluoxetine 
was obtained from Quality Pharma, Dibrugarh. morphine was 
obtained from Verve healthcare Ltd, Delhi. naloxone was obtained 
from Neon laboratories Ltd. yohimbine was obtained from himedia 
Laboratory Pvt. Ltd, Bangalore. ondansetron obtained from Alkem 
Laboratories Ltd, East Sikkim. Diclofenac Sodium was obtained from 
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NOVARTIS co. Pvt. Ltd. Glacial acetic acid was obtained from 
Qualigens (Fisher scientific). 
Dose selection 
Dose of amitriptyline used in this experiment was 20 mg/kg [13, 14], 
fluoxetine 20 mg/kg [15], morphine 5 mg/kg [16], naloxone3 mg/kg 
[17], yohimbine 2 mg/kg [18], ondansetron 0.1 mg/kg [7] and 
diclofenac 5 mg/kg [19]. 
Experimental animals 
Healthy male swiss albino mice (25-35 grams) were taken from the 
Central Animal House, Assam Medical College (registration no. 
634/02/a/CPCSEA dated 19/05/02). The animals were housed in 
standard cages under standard conditions of light and dark cycle 
and maintained under normal room temperature. The animals were 
fed with a normal diet and water ad libitum. Before commencing the 
work permission from the Institutional Animal Ethics Committee 
was taken and conducted according to CPCSEA guidelines.  
Experimental design 
Albino mice (male) weighing 25-35 grams were taken and divided 
into 11 groups.  
Group A-Control (Distilled water),  
Group B-Amitriptyline 20 mg/kg,  
Group C-Fluoxetine 20 mg/kg,  
Group D-Morphine 5 mg/kg 
Group E-Amitriptyline 20 mg/kg+Morphine 5 mg/kg,  
Group F-Amitriptyline 20 mg/kg+Naloxone 3 mg/kg,  
Group G-Amitriptyline 20 mg/kg+Yohimbine 2 mg/kg,  
Group H-Amitriptyline 20 mg/kg+Ondansetron 0.1 mg/kg,  
Group I-Fluoxetine20 mg/kg+morphine 5 mg/kg, 
Group J-Fluoxetine 20 mg/kg+Naloxone 3 mg/kg, 
Group K-Fluoxetine 20 mg/kg+Yohimbine 2 mg/kg 
Group L-Fluoxetine 20 mg/kg+Ondansetron 0.1 mg/kg. 
Central analgesic activity 
The central analgesic activity was tested by Hot Plate method in albino 
mice. Mice were placed on an aluminum hot plate kept at 55 °C [20]. 
The reaction time is the time eclipsed between placing the animal on 
a hot plate to first paw licking (hind paw) or Jumping behavior 
shown by the animal (whichever appear first) [21]. The Pre-Drug 
reaction time for each animal was recorded. After that Distilled 
water and test, drugs were injected intraperitoneally and reaction 
time was noted at 20, 60 and 90 min after drug administration. Cut 
off time of 15 seconds was taken to avoid thermal injury to the paws 
of mice [22]. Morphine (5 mg/kg I. P.) was used as a reference 
standard [16]. 
Peripheral analgesic activity testing 
The peripheral analgesic activity was tested by glacial acetic acid-
induced Writhing test in albino mice. Writhing or stretching 
syndrome is characterized by a wave of contractions of the 
abdominal musculature followed by extension of the hind limbs 
[23]. 
Distilled water and test drugs were injected intraperitoneally (I. P) 
15 min before subjecting the animals to 0.6% acetic acid I. P. (1 
ml/100 gram) [22]. The number of writhing responses was counted 
for 20 min. Index of analgesia is referred to as the percentage of 
protection against abdominal constriction [24]. It is calculated as:  
Index of analgesia= No.of writhing in control group–No.of writhing in treated group
No of writhing in control group.
 
Diclofenac Sodium (5 mg/kg I. P.) was used as a reference standard 
[19]. 
Statistical analysis 
The results were statistically analyzed using one-way ANOVA 
followed by dunnett's multiple comparison tests and bonferroni's 
test. Student's t-test (paired) was applied to compare pre-drug 
reaction time with post-drug reaction time at 20, 60 and 90 min 
individually. The statistical analysis was done using Graph pad 
prism software version 5.00. p values<0.05 were considered 
significant. 
RESULTS 
Analgesic activity of amitriptyline and fluoxetine on a hot plate 
and acetic acid-induced writhing test 
The results are depicted in table 1. In hot plate method, both 
amitriptyline and fluoxetine-treated mice showed a significant 
increase in mean reaction time compared to the control group at 20, 
60 and 90 min. 
In acetic acid-induced writhing test, with regard to a number of 
writhing movement, both amitriptyline and fluoxetine-treated 
animals showed significant protection when compared to control 
group. Regarding percentage protection, amitriptyline group showed 
79% protection and fluoxetine group showed 63% protection. 
It is seen that amitriptyline is superior to fluoxetine with regard to 
analgesic activity in both the models both as a central analgesic and 
as a peripherally acting agent. 
 
Table 1: Analgesic activity of amitriptyline and fluoxetine in hot plate test and acetic acid-induced writhing test 
Group Treatment  Reaction time in hot plate test (sec) Acetic acid induced writhing test  
Pre-drug  20 min 60 min 90 min No of wriths % protection 
A Control 4.6±0.24 4.36±0.18 3.888±0.35 4.080±0.25 59.2±1.9  
B Amitriptyline 4.582±0.37 7.528±0.41a,b 8.266±0.37a,b 9.502±0.48a,b 12.4±0.5a 79% 
C Fluoxetine 4.226±0.36 6.524±0.33a,b,c 6.496±0.05a,b,c 6.432±0.53a,b,c 21.6±1.1a,c 63% 
D Morphine 4.236±0.11 7.794±0.11a,b 9.540±0.21a,b 10.11±0.24a,b 10±0.6a 82% 
Values are expressed as mean±SEM; (n=5). Oneway ANOVA followed by dunnett’s multiple comparison test. ANOVA followed by bonferroni’s test 
was done between group B and C. Paired t test was done between pre-drug reaction time versus post drug reaction time at 20, 60 and 90 min. a 
p<0.05 when compared to control group. b p<0.05 when compared to pre-drug reaction time. c p<0.05 when compared to group B. 
 
Analgesic activity of amitriptyline and its combination with 
morphine, naloxone, yohimbine, and ondansetron in hot plate 
and acetic acid writhing test 
The results are depicted in table 2. In central analgesic model, 
amitriptyline+morphine group showed a statistically significant increase 
in mean reaction time at 60 and 90 min when compared to amitriptyline 
group. Amitriptyline+naloxone, amitriptyline+ yohimbine, and 
amitriptyline+ondansetron group recorded a significant decrease in 
mean reaction time was seen at 20, 60 and 90 min when compared 
to amitriptyline group. 
In the peripheral analgesic model, amitriptyline+morphine group showed 
a significant decrease in the number of writhing and an increase in 
percentage protection while amitriptyline+naloxone, amitriptyline+ 
yohimbine and amitriptyline+ondansetron group recorded a significant 
increase in the number of writhing and a decrease in percentage 
protection when compared to amitriptyline treated group. 
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Table 2: Analgesic activity of amitriptyline and its combination with morphine, naloxone, yohimbine and ondansetron in the hot plate and 
acetic acid writhing test 
Group Treatment  Reaction time in hot plate (sec) Acetic acid induced writhing test 
Pre-drug 20 min 60 min 90 min No of wriths % protection 
B Amitriptyline 4.58±0.37 7.53±0.41b 8.27±0.37b 9.5±0.48b 12.4±0.5 79% 
E Amitriptyline 
+Morphine 
4.4±0.39 7.99±0.43b 13.11± 
0.62a,b 
13.83±0.65a,b 0a 100% 
F Amitriptyline 
+Naloxone 
4.8±0.59 1.77±0.55a,b 1.044±0.17a,b 1.3±0.17a,b 54.2±1.3a 8% 
G Amitriptyline 
+Yohimbine 
4.3±0.53 1.68±0.44a,b 1.238±0.22a,b 1.67±0.40a,b 58±0.9a 2% 
H Amitriptyline+ 
Ondansetron 
4.68±0.41 2.85±0.44a,b 2.998±0.76a,b 1.09±0.15a,b 50.4±0.9a 14% 
Values are expressed as mean±SEM; (n=5). One-way ANOVA followed by dunnett’s test. Paired t-test was done between pre-drug reaction time 
versus post drug reaction time at 20, 60 and 90 min. a=p<0.05 when compared to group B. b=p<0.05 when compared to pre-drug reaction time. 
 
Analgesic activity of fluoxetine and its combinations with 
morphine, naloxone yohimbine and ondansetron in hot plate 
and acetic acid writhing test 
The results are depicted in table 3. In central analgesic model, 
fluoxetine+morphine group showed a statistically significant increase 
in mean reaction time at 60 and 90 min when compared to fluoxetine 
treated group. Fluoxetine+naloxone, fluoxetine+yohimbine and 
fluoxetine+ondansetron group showed a significant decrease in mean 
reaction time at 20, 60 and 90 min, when compared to fluoxetine, 
treated group. 
In the peripheral analgesic model, the fluoxetine+morphine group 
showed a significant decrease in the number of writhing and an 
increase in percentage protection while fluoxetine+naloxone, 
fluoxetine+yohimbine and fluoxetine+ondansetron group recorded a 
significant increase in the number of writhing and a decrease in 
percentage protection when compared to Fluoxetine treated group. 
 
Table 3: Analgesic activity of fluoxetine and its combinations with morphine, naloxone yohimbine and ondansetron in hot plate and acetic 
acid writhing test 
Group Treatment  Reaction time in Hotplate (sec) Acetic acid induced writhing test 
Pre-drug  20 min 60 min 90 min No of  wriths % protection 
C Fluoxetine 4.22±0.35 6.52±0.33b 6.49±0.51b 6.4±0.53b 21.6±1 63% 
I Fluoxetine 
+Morphine 
4.11±0.35 7.48±0.29b 10.02± 
0.97a,b 
































Values are expressed as mean±SEM; (n=5). One-way ANOVA followed by Dunnett’s test. Paired t-test was done between pre-drug reaction time 
versus post-drug reaction time at 20, 60 and 90 min. a p<0.05 when compared to group C. b p<0.05 when compared to pre-drug reaction time. 
 
DISCUSSION 
In our present study, we found that both amitriptyline and fluoxetine 
are effective as an analgesic agent in both the central model and 
peripheral model of analgesic activity.  
Regarding central anti-nociceptive action, in our experiment, 
antinociceptive actions of amitriptyline and fluoxetine were 
synergized by morphine, and it was antagonized by naloxone (opioid 
receptor antagonist), yohimbine (α-2 antagonist) and ondansetron 
(5-HT3receptor antagonist) in hot plate method. Thus, it seems that 
their central analgesic action involves opioidergic, serotonergic and 
noradrenergic pathways. Fluoxetine and amitriptyline are reported 
to increase the density of opioid receptors [25-27]. They also cause 
the release of endogenous opioid peptides [27]. Acetorphan 
(encephalinase inhibitor) potentiated the antinociceptive activity of 
antidepressants indicating a clear role of opioidergic system in 
antidepra essant-induced nociception [28]. These drugs are also 
reported to act directly on opioid receptors [29]. Antidepressants 
can displace opioids from binding sites in radioligand binding assays 
[30]. For their opioidergic action, fluoxetine may be acting through µ 
[31, 32] opioid receptor. Amitriptyline seems to be acting through µ 
[28], κ [29th] and δ [28, 29] opioid receptors. Regarding the 
involvement of serotonergic and noradrenergic pathway, NE and 5-HT 
may activate pain inhibitory interneurons in the superficial layers of 
dorsal horn [33]. 5-HT facilitates the release of beta-endorphin [34]. 
Antidepressants which increase the availability of NE and 5HT leads to 
enhancement of opioid pathways [35]. The opioid peptides also 
modulate Locus Coeruleus (LC). Activation of presynaptic delta-opioid 
receptors inhibits GABA release and thus excites spinally projecting 
noradrenergic LC neurons [36]. Alpha-2 adrenoceptors modulate pain 
in many ways. They may cause presynaptic inhibition (at the level of 
primary afferent nociceptors), inhibition of pain-relaying 
spinothalamic neurons (postsynaptic inhibition). Alpha-2 
Cadrenoceptors present on excitatory interneurons in the dorsal horn 
of spinal cord contributes to spinal control of pain [4]. 
Coming to peripheral antinociceptive action, anti-nociceptive actions 
of amitriptyline and fluoxetine were synergized by morphine and 
antagonized by naloxone, yohimbine, and ondansetron in the 
peripheral analgesic model (acetic acid-induced writhing test). Thus, 
it can be said that their peripheral analgesic action also involves 
opioidergic, noradrenergic and serotonergic mechanisms. A 
prostaglandin synthesis inhibitory action may also be present. 
Regarding the involvement of opioidergic system in the peripheral 
antinociceptive action, it is a known fact that immune cells contain 
numerous opioid peptides but the predominant opioid peptides 
involved in immune-cell mediated antinociception are thought to be 
endorphin and encephalin [37]. Endogenous opioid peptides are 
released by immune cells to reduce inflammatory pain. 
noradrenaline, corticotropin-releasing factor (CRF) and interleukin-
1α stimulate immune cells to secrete their opioid peptides [37]. 
These opioid peptides cause inhibition of pro-inflammatory 
neuropeptide release and sensory neuron excitability [38]. Opioid 
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mimicking or enhancing a property of the antidepressants may also 
play a role in their peripheral analgesic action [30]. Regarding the 
involvement of serotonergic pathway in the peripheral 
antinociceptive action, in our study, in the peripheral analgesic 
model, 5-HT3 antagonist ondansetron antagonized the 
antinociceptive action of both amitriptyline and fluoxetine in the 
acetic acid writhing model. Similar observation was also made by 
Kesim M et al., 2005 [7] with paroxetine. But the exact mechanism of 
how peripheral 5-HT3 modulation is involved in the peripheral 
antinociceptive action of both the drugs is still not clear. Pain 
sensation in acetic acid induced writhing method is due to 
prostaglandin biosynthesis (Via cyclooxygenase pathway) triggered 
by localized inflammatory reaction [39, 40]. So, agents which reduce 
the number of writhing will render their effect preferably by 
inhibition of prostaglandin biosynthesis [39, 40]. In our study, both 
the antidepressants were effective in preventing acetic acid-induced 
writhing movements in mice. So, a prostaglandin synthesis 
inhibitory action of the drugs (amitriptyline and fluoxetine) also may 
be present and which may be responsible in part for their peripheral 
antinociceptive action. This needs further investigation. 
CONCLUSION 
In this study, it was found that both amitriptyline and fluoxetine has 
antinociceptive property and amitriptyline is a better 
antinociceptive agent than fluoxetine. Their mechanism of central 
antinociceptive action may involve opioidergic actions, serotonin 
reuptake inhibitory action, and norepinephrine reuptake inhibitor 
property of both the drugs. A complex interaction of all the three 
systems may be playing the main role. 
Regarding peripheral antinociceptive action, it has been observed 
that their interaction with opioidergic system and noradrenaline 
mediated enhancement of peripheral opioidergic system seems to 
play the main role. Additional 5-HT3 receptor-mediated or 
prostaglandin synthesis inhibitory action may also be involved in 
their peripheral analgesic action. Again, antidepressants are known 
to interact with many other receptor systems. So, some of these 
systems may also take part in their analgesic action. This needs 
further investigation. 
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